[PANAMY] YoY Annualized Quarter Result on 31-Dec-2012 [#3]

Stock
[PANAMY] PANASONIC MANUFACTURING MSIA
Announcement Date
27-Feb-2013
Admission Sponsor
-
Sponsor
-
Financial Year
31-Mar-2013
Quarter
31-Dec-2012 [#3]
Profit Trend
QoQ- 13.23%
YoY- 3.43%
Quarter Report
Latest QR
Upcoming QR
PANAMY's Result
PANAMY's Financial Summary
View:
Show?
Annualized Quarter Result
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Revenue 1,116,006 1,001,117 938,264 902,600 890,776 814,664 701,293 8.04%
PBT 195,818 130,694 106,408 105,405 98,712 114,616 81,929 15.62%
Tax -48,232 -29,797 -23,921 -24,121 -20,122 -23,948 -15,933 20.26%
NP 147,586 100,897 82,486 81,284 78,589 90,668 65,996 14.34%
-
NP to SH 147,586 100,897 82,486 81,284 78,589 90,668 65,996 14.34%
-
Tax Rate 24.63% 22.80% 22.48% 22.88% 20.38% 20.89% 19.45% -
Total Cost 968,420 900,220 855,777 821,316 812,186 723,996 635,297 7.27%
-
Net Worth 752,035 703,438 644,515 660,916 646,944 639,330 614,740 3.41%
Dividend
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Div 12,149 12,149 12,149 12,149 12,149 12,143 12,221 -0.09%
Div Payout % 8.23% 12.04% 14.73% 14.95% 15.46% 13.39% 18.52% -
Equity
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Net Worth 752,035 703,438 644,515 660,916 646,944 639,330 614,740 3.41%
NOSH 60,746 60,746 60,746 60,746 60,746 60,715 61,107 -0.09%
Ratio Analysis
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
NP Margin 13.22% 10.08% 8.79% 9.01% 8.82% 11.13% 9.41% -
ROE 19.62% 14.34% 12.80% 12.30% 12.15% 14.18% 10.74% -
Per Share
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
RPS 1,837.17 1,648.04 1,544.57 1,485.86 1,466.39 1,341.78 1,147.64 8.15%
EPS 242.67 165.33 136.00 133.33 129.33 149.33 108.00 14.43%
DPS 20.00 20.00 20.00 20.00 20.00 20.00 20.00 0.00%
NAPS 12.38 11.58 10.61 10.88 10.65 10.53 10.06 3.51%
Adjusted Per Share Value based on latest NOSH - 60,746
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
RPS 1,809.50 1,623.21 1,521.30 1,463.48 1,444.31 1,320.90 1,137.08 8.04%
EPS 239.30 163.60 133.74 131.79 127.42 147.01 107.01 14.34%
DPS 19.70 19.70 19.70 19.70 19.70 19.69 19.82 -0.10%
NAPS 12.1935 11.4056 10.4502 10.7161 10.4896 10.3661 9.9674 3.41%
Price Multiplier on Financial Quarter End Date
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Date 31/12/15 31/12/14 31/12/13 31/12/12 30/12/11 30/12/10 31/12/09 -
Price 24.28 18.50 22.32 20.40 20.04 18.50 12.52 -
P/RPS 1.32 1.12 1.45 1.37 1.37 1.38 1.09 3.24%
P/EPS 9.99 11.14 16.44 15.25 15.49 12.39 11.59 -2.44%
EY 10.01 8.98 6.08 6.56 6.46 8.07 8.63 2.50%
DY 0.82 1.08 0.90 0.98 1.00 1.08 1.60 -10.53%
P/NAPS 1.96 1.60 2.10 1.88 1.88 1.76 1.24 7.92%
Price Multiplier on Announcement Date
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Date 26/02/16 26/02/15 26/02/14 27/02/13 22/02/12 10/02/11 24/02/10 -
Price 25.20 21.18 21.72 20.30 20.80 18.10 12.80 -
P/RPS 1.37 1.29 1.41 1.37 1.42 1.35 1.12 3.41%
P/EPS 10.37 12.75 16.00 15.17 16.08 12.12 11.85 -2.19%
EY 9.64 7.84 6.25 6.59 6.22 8.25 8.44 2.23%
DY 0.79 0.94 0.92 0.99 0.96 1.10 1.56 -10.71%
P/NAPS 2.04 1.83 2.05 1.87 1.95 1.72 1.27 8.21%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment